WallStreetZenWallStreetZen

NYSE: DLB
Dolby Laboratories Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Dolby Laboratories revenue was $1.35B for the trailing 12 months ending Sep 26, 2025, with -2.9% growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 26, 2025 was $307.0M, down 2.7% from last quarter. For the last reported fiscal year 2025 ending Sep 26, 2025, DLB annual revenue was $1.3B, with 5.9% growth year-over-year.

DLB past revenue growth

How has DLB's revenue growth performed historically?

Company
5.92%
Industry
7.09%
Market
77.73%
DLB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DLB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DLB's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DLB revenue history

Current Revenue
$1.3B
Current Earnings
$255.0M
Current Profit Margin
18.9%
DLB's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when DLB announces revenue.

DLB Revenue History By Year

DLB Yearly RevenueDLB RevenueDLB ChangeDLB Revenue Growth
2025-09-26$1.35B$75.41M+5.92%
2024-09-27$1.27B-$26.02M-2.00%
2023-09-29$1.30B$45.95M+3.66%
2022-09-30$1.25B-$27.46M-2.14%
2021-09-24$1.28B$119.46M+10.28%
2020-09-25$1.16B-$79.83M-6.43%
2019-09-27$1.24B$187.02M+17.73%
2018-09-28$1.05B-$25.58M-2.37%
2017-09-29$1.08B$54.44M+5.31%
2016-09-30$1.03B$55.10M+5.68%
2015-09-25$970.64M$10.46M+1.09%
2014-09-26$960.18M$50.50M+5.55%
2013-09-27$909.67M-$23.34M-2.50%
2012-09-28$933.01M-$28.05M-2.92%
2011-09-30$961.07M$38.35M+4.16%
2010-09-24$922.71M$203.21M+28.24%
2009-09-25$719.50M$79.27M+12.38%
2008-09-26$640.23M$158.20M+32.82%
2007-09-28$482.03M$90.49M+23.11%
2006-09-29$391.54M$63.58M+19.38%
2005-09-30$327.97M$38.93M+13.47%
2004-09-24$289.04M$71.57M+32.91%
2003-09-26$217.47M$55.60M+34.35%
2002-09-27$161.87MN/AN/A

1 of 2

Dolby Laboratories Revenue FAQ

What was DLB's revenue last quarter?

On Invalid Date, Dolby Laboratories (NYSE: DLB) reported Q3 2025 revenue of $307.02 million up 0.73% year over year. In the same quarter last year, Dolby Laboratories's revenue was $304.81 million.

What was Dolby Laboratories's revenue in 2025?

Dolby Laboratories's annual revenue for the twelve months ending Sep 26, 2025 was $1.35 billion, a 5.92% increase year over year.

How much does Dolby Laboratories make in a day?

Based on Dolby Laboratories annual revenue for the past five years, DLB makes an average of $3,538,435.07 per day.

What was Dolby Laboratories's annual revenue growth in the past year?

As of Q1 2026, Dolby Laboratories's revenue has grown 5.92% year over year. This is 1.17 percentage points lower than the US Specialty Business Services industry revenue growth rate of 7.09%. Dolby Laboratories's revenue in the past year totaled $1.35 billion.

How much does Dolby Laboratories make in a year?

Dolby Laboratories's revenue by year for the past five years is:
  • Dolby Laboratories's revenue for the twelve months ending Sep 26, 2025 was $1.35 billion, a 5.92% increase year over year.
  • Dolby Laboratories's annual revenue for Sep 27, 2024 was $1.27 billion, a 2% decrease from 2023.
  • Dolby Laboratories's annual revenue for 2023 was $1.30 billion, a 3.66% increase from 2022.
  • Dolby Laboratories's annual revenue for 2022 was $1.25 billion, a 2.14% decrease from 2021.
  • Dolby Laboratories's annual revenue for 2021 was $1.28 billion, a 10.28% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.